Wyeth depression/hot flash drug faces hurdles
SignOn San Diego - NEW YORK – Wyeth could win U.S. approval Monday for a depression drug derived from the company's widely used Effexor XR, but its launch will be delayed by factory problems and issues with nausea, according to Wyeth and industry analysts. The
Source: www.signonsandiego.com
GSK boost as it plans China venture
This is Money - GSK faces copycat competition to anti-depression drug Wellbutrin and Zofran, which treats vomiting. But it will supplement lost sales with the introduction of Tykerb, a new drug for late stage breast cancer and Cervarix, a wannabe blockbuster
Source: www.thisismoney.co.uk
Drug abuse and dependence
HealthCentral.com - Drug dependence (addiction) is compulsive use of a substance despite negative consequences which can be severe; drug abuse is simply excessive use of a drug or use of a drug for purposes for which it was not medically intended. Physical dependence on
Source: www.healthcentral.com
This week's contents
Jacksonville Business Journal - tax crisis has entrepreneurs considering drastic action [Thursday] Nemours, BCBS reach agreement [Thursday] Winn-Dixie to get $19M in IRS settlement [Thursday] MPS Group's annual earnings climb 26% [Thursday] Ranbaxy gets FDA approval for depression drug
Source: jacksonville.bizjournals.com
Click here for more information about depression clinic depression clinic
